FT 10718: Biotechnology Portfolio Series 61 - Cash (FRGBDX) Q1 2025 Earnings

Feb 28Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
999
333
-333
-999

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨FT 10718: Biotechnology Portfolio Series 61 - Cash⁩ (⁦FRGBDX⁩) will report earnings of for ⁦Q1 2025⁩ on February 28, 2025.

0 Comments

Share your thoughts